Strategic Phased Launch of Tirzepatide for Obes...

By João L. Carapinha

October 8, 2024

The phased launch of tirzepatide obesity treatment, is a significant development in combating obesity. The obesity injection, also known as Mounjaro or Zepbound, is developed by Eli Lilly and aims to provide a new treatment option for those strugg...
Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anx...
The Trump Drug Policy Change: A Reverse Course
WHO Introduces HPV Single-Dose Vaccine to Boost Cervical Cancer Elimination E...
Created and Validated by FDA: AI Drug Safety Surveillance Tool
The Role of School-Based Health Centres in Advancing Health Equity
Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism
Mental Health Planning with System Dynamics Modelling in Australia
Understanding the Impact of COVID-19 on Youth Mental Health
Cost-Effectiveness of Integrated Care for Children with Chronic Conditions
Eli Lilly’s Alzheimer’s Drug Kisunla Gains Approval in Japan
Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors
The Impact of Atrial Fibrillation on Quality of Life and Healthcare Costs